PHARMACEUTICAL STATISTICS

Note: The following journal information is for reference only. Please check the journal website for updated information prior to submission.

Journal Title

PHARM STAT

ISSN / eISSN

1539-1604 / 1539-1612

Aims and Scope

Pharmaceutical Statistics is an industry-led initiative, tackling real problems in statistical applications. The Journal publishes papers that share experiences in the practical application of statistics within the pharmaceutical industry. It covers all aspects of pharmaceutical statistical applications from discovery, through pre-clinical development, clinical development, post-marketing surveillance, consumer health, production, epidemiology, and health economics.

The Journal is both international and multidisciplinary. It includes high quality practical papers, case studies and review papers.

Subject Area

PHARMACOLOGY & PHARMACY

STATISTICS & PROBABILITY

CiteScore

2.00

View Trend

CiteScore Ranking

Category	Quartile	Rank
Mathematics - Statistics and Probability	Q2	#121/262
Mathematics - Pharmacology (medical)	Q3	#174/260
Mathematics - Pharmacology	Q3	#218/301

Web of Science Core Collection

Science Citation Index Expanded (SCIE)	Social Sciences Citation Index (SSCI)
Indexed	-

Category (Journal Citation Reports 2023)	Quartile
PHARMACOLOGY & PHARMACY - SCIE	Q4
STATISTICS & PROBABILITY - SCIE	Q2

H-index

Country/Area of Publication

ENGLAND

Publisher

John Wiley and Sons Ltd

Publication Frequency

Quarterly

Year Publication Started

2002

Annual Article Volume

Open Access

Contact

JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, USA, NJ, 07030

Popular journals in the same field
Recent articles

Conditional power and information fraction calculations at an interim analysis for random coefficient models: (2023) Sandra A. Lewis, Kevin J. Carroll, Todd DeVries, Jonathan Barratt

Probability of success and group sequential designs: (2023) Andrew P. Grieve

Enrollment forecast for clinical trials at the portfolio planning phase based on site‐level historical data: (2023) Sheng Zhong, Yunzhao Xing, Mengjia Yu, Li Wang

Frequentist and Bayesian tolerance intervals for setting specification limits for left‐censored gamma distributed drug quality attributes: (2023) Richard O. Montes

Group sequential design with maximin efficiency robust test for immunotherapy with generalized delayed treatment effect: (2023) Bosheng Li, Jingyi Zhang, Wenyi Yang, Liwen Su, Fangrong Yan

Effects of duration of follow‐up and lag in data collection on the performance of adaptive clinical trials: (2023) Anders Granholm, Theis Lange, Michael O. Harhay, Aksel Karl Georg Jensen, Anders Perner, Morten Hylander Møller, Benjamin Skov Kaas‐Hansen

Duration of and time to response in oncology clinical trials from the perspective of the estimand framework: (2023) Hans‐Jochen Weber, Stephen Corson, Jiang Li, François Mercier, Satrajit Roychoudhury, Martin Oliver Sailer, Steven Sun, Alexander Todd, Godwin Yung,

A conservative approach to leveraging external evidence for effective clinical trial design: (2023) Fabio Rigat

Evaluating hybrid controls methodology in early‐phase oncology trials: A simulation study based on the MORPHEUS‐UC trial: (2023) Guanbo Wang, Melanie Poulin‐Costello, Herbert Pang, Jiawen Zhu, Hans‐Joachim Helms, Irmarie Reyes‐Rivera, Robert W. Platt, Menglan Pang, Artemis Kouko...

A marginalized two‐part joint model for a longitudinal biomarker and a terminal event with application to advanced head and neck cancers: (2023) Denis Rustand, Laurent Briollais, Virginie Rondeau

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started